{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T01:04:49Z","timestamp":1794013489788,"version":"4.8.0"},"reference-count":38,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,4,15]],"date-time":"2022-04-15T00:00:00Z","timestamp":1649980800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:p>Idiopathic inflammatory myopathies (IIM) are considered systemic diseases involving different organs and some subtypes are associated with increased cancer risk. In this review, we provide a comprehensive summary of the current use and potential applications of (semi-)quantitative [<jats:sup>18<\/jats:sup>F]FDG-PET\/CT indices in patients with IIM focusing on dermatomyositis and polymyositis. Visual interpretation and (semi-)quantitative [<jats:sup>18<\/jats:sup>F]FDG-PET indices have a good overall performance to detect muscle activity but objective, robust and standardized interpretation criteria are currently lacking. [<jats:sup>18<\/jats:sup>F]FDG-PET\/CT is a suitable modality to screen for malignancy in patients with myositis and may be a promising tool to detect inflammatory lung activity and to early identify patients with rapidly progressive lung disease. The latter remains to be determined in large, prospective comparative trials.<\/jats:p>","DOI":"10.3389\/fmed.2022.883727","type":"journal-article","created":{"date-parts":[[2022,4,15]],"date-time":"2022-04-15T05:40:30Z","timestamp":1650001230000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":9,"title":["The Role of Quantitative and Semi-quantitative [18F]FDG-PET\/CT Indices for Evaluating Disease Activity and Management of Patients With Dermatomyositis and Polymyositis"],"prefix":"10.3389","volume":"9","author":[{"given":"Halil","family":"Yildiz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"D'abadie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Gheysens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,4,15]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"715","DOI":"10.7326\/0003-4819-122-9-199505010-00010","article-title":"NIH conference. Myositis: immunologic contributions to understanding cause, pathogenesis, and therapy","volume":"122","author":"Plotz","year":"1995","journal-title":"Ann Intern Med."},{"key":"B2","doi-asserted-by":"publisher","first-page":"1734","DOI":"10.1056\/NEJMra1402225","article-title":"Inflammatory muscle diseases","volume":"372","author":"Dalakas","year":"2015","journal-title":"N Engl J Med."},{"key":"B3","doi-asserted-by":"publisher","first-page":"1528","DOI":"10.1001\/jamaneurol.2018.2598","article-title":"Development of a new classification system for idiopathic inflammatory myopathies based on clinical manifestations and myositis-specific autoantibodies","volume":"75","author":"Mariampillai","year":"2018","journal-title":"JAMA Neurol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1056\/NEJM197502202920807","article-title":"Polymyositis and dermatomyositis (second of two parts)","volume":"292","author":"Bohan","year":"1975","journal-title":"N Engl J Med"},{"key":"B5","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1016\/S0140-6736(03)14368-1","article-title":"Polymyositis and dermatomyositis","volume":"362","author":"Dalakas","year":"2003","journal-title":"Lancet."},{"key":"B6","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1097\/00002281-199711000-00008","article-title":"Oddis CV. Classification criteria for the idiopathic inflammatory myopathies","volume":"9","author":"Targoff","year":"1997","journal-title":"Curr Opin Rheumatol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1067\/mjd.2002.120621","article-title":"Would a new name hasten the acceptance of amyopathic dermatomyositis (dermatomyositis sin\u00e9 myositis) as a distinctive subset within the idiopathic inflammatory dermatomyopathies spectrum of clinical illness?","volume":"46","author":"Sontheimer","year":"2002","journal-title":"J Am Acad Dermatol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.nmd.2004.02.006","article-title":"119th ENMC International Workshop: trial design in adult idiopathic inflammatory myopathies, with the exception of inclusion body myositis, 10-12 October 2003. Naarden, The Netherlands","volume":"14","author":"Hoogendijk","year":"2004","journal-title":"Neuromuscul Disord"},{"key":"B9","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1097\/01.md.0000173991.74008.b0","article-title":"Novel classification of idiopathic inflammatory myopathies based on overlap syndrome features and autoantibodies: analysis of 100 French Canadian patients","volume":"84","author":"Troyanov","year":"2005","journal-title":"Medicine."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1955","DOI":"10.1136\/annrheumdis-2017-212786","article-title":"2017 European League Against Rheumatism\/American College of Rheumatology classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups","volume":"76","author":"Lundberg","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"B11","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1002\/acr.22583","article-title":"Distinctions between diagnostic and classification criteria?","volume":"67","author":"Aggarwal","year":"2015","journal-title":"Arthritis Care Res."},{"key":"B12","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1093\/rheumatology\/kem088","article-title":"The role of MRI in the assessment of polymyositis and dermatomyositis","volume":"46","author":"Tomasov\u00e1 Studynkov\u00e1","year":"2007","journal-title":"Rheumatology."},{"key":"B13","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.1007\/s00296-009-0890-y","article-title":"Whole-body MRI: a helpful diagnostic tool for juvenile dermatomyositis case report and review of the literature","volume":"29","author":"Tzaribachev","year":"2009","journal-title":"Rheumatol Int."},{"key":"B14","doi-asserted-by":"publisher","first-page":"S295","DOI":"10.1148\/radiographics.20.suppl_1.g00oc18s295","article-title":"Abnormal signal intensity in skeletal muscle at MR imaging: patterns, pearls, and pitfalls","volume":"20","author":"May","year":"2000","journal-title":"Radiographics."},{"key":"B15","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.semarthrit.2018.10.021","article-title":"Positron emission tomography costs less to patients than conventional screening for malignancy in dermatomyositis","volume":"49","author":"Kundrick","year":"2019","journal-title":"Semin Arthritis Rheum."},{"key":"B16","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1016\/j.amjmed.2009.11.012","article-title":"Conventional cancer screening versus PET\/CT in dermatomyositis\/polymyositis","volume":"123","author":"Selva-O'Callaghan","year":"2010","journal-title":"Am J Med."},{"key":"B17","doi-asserted-by":"publisher","first-page":"1659","DOI":"10.3899\/jrheum.111597","article-title":"Detection of inflammatory lesions by f-18 fluorodeoxyglucose positron emission tomography in patients with polymyositis and dermatomyositis","volume":"39","author":"Owada","year":"2012","journal-title":"J Rheumatol."},{"key":"B18","first-page":"570","article-title":"18F-Fluorodeoxyglucose positron emission tomography for the assessment of myositis: a case series","volume":"30","author":"Pipitone","year":"2012","journal-title":"Clin Exp Rheumatol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1093\/rheumatology\/ket112","article-title":"[18F]FDG uptake in proximal muscles assessed by PET\/CT reflects both global and local muscular inflammation and provides useful information in the management of patients with polymyositis\/dermatomyositis","volume":"52","author":"Tanaka","year":"2013","journal-title":"Rheumatology."},{"key":"B20","doi-asserted-by":"publisher","first-page":"e006763","DOI":"10.1136\/bmjopen-2014-006763","article-title":"Clinical values of FDG PET in polymyositis and dermatomyositis syndromes: imaging of skeletal muscle inflammation","volume":"5","author":"Tateyama","year":"2015","journal-title":"BMJ Open."},{"key":"B21","doi-asserted-by":"publisher","first-page":"2297","DOI":"10.1007\/s10067-017-3794-3","article-title":"Multiple values of 18F-FDG PET\/CT in idiopathic inflammatory myopathy","volume":"36","author":"Li","year":"2017","journal-title":"Clin Rheumatol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"5023","DOI":"10.3892\/etm.2018.6066","article-title":"[18F]Fluorodeoxyglucose positron emission tomography\/computed tomography for diagnosing polymyositis\/dermatomyositis","volume":"15","author":"Sun","year":"2018","journal-title":"Exp Ther Med."},{"key":"B23","doi-asserted-by":"publisher","first-page":"2345","DOI":"10.1093\/rheumatology\/kez447","article-title":"Muscle fluorodeoxyglucose uptake assessed by positron emission tomography-computed tomography as a biomarker of inflammatory myopathies disease activity","volume":"58","author":"Matuszak","year":"2019","journal-title":"Rheumatology."},{"key":"B24","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1097\/MNM.0000000000000981","article-title":"18F-FDG PET\/CT versus conventional investigations for cancer screening in autoimmune inflammatory myopathy in the era of novel myopathy classifications","volume":"40","author":"Maliha","year":"2019","journal-title":"Nucl Med Commun"},{"key":"B25","doi-asserted-by":"publisher","first-page":"6708","DOI":"10.1007\/s00330-019-06302-9","article-title":"Clinical value of a [18F]-FDG PET-CT muscle-to-muscle SUV ratio for the diagnosis of active dermatomyositis","volume":"29","author":"Martis","year":"2019","journal-title":"Eur Radiol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1111\/1346-8138.14758","article-title":"Clinical value of 18 F-fluorodeoxyglucose positron emission tomography\/computed tomography for interstitial lung disease and myositis in patients with dermatomyositis","volume":"46","author":"Motegi","year":"2019","journal-title":"J Dermatol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"e03707","DOI":"10.1016\/j.heliyon.2020.e03707","article-title":"Value of 18F-FDG PET\/CT in the detection of occult malignancy in patients with dermatomyositis","volume":"6","author":"Li","year":"2020","journal-title":"Heliyon."},{"key":"B28","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s41824-020-00084-w","article-title":"18F-FDG PET\/CT in patients with polymyositis\/dermatomyositis: correlation with serum muscle enzymes","volume":"4","author":"Arai-Okuda","year":"2020","journal-title":"Eur J Hybrid Imaging"},{"key":"B29","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1186\/s13075-021-02578-9","article-title":"The lungs were on fire: a pilot study of 18F-FDG PET\/CT in idiopathic-inflammatory-myopathy-related interstitial lung disease","volume":"23","author":"Liang","year":"2021","journal-title":"Arthritis Res Ther."},{"key":"B30","doi-asserted-by":"publisher","first-page":"779272","DOI":"10.3389\/fmed.2021.779272","article-title":"Radiological characteristics of patients with anti-MDA5-antibody-positive dermatomyositis in 18F-FDG PET\/CT: a pilot study","volume":"8","author":"Cao","year":"2021","journal-title":"Front Med."},{"key":"B31","doi-asserted-by":"publisher","first-page":"151940","DOI":"10.1016\/j.semarthrit.2021.12.008","article-title":"Cancer screening in idiopathic inflammatory myopathies: ten years experience from a single center","volume":"53","author":"Trallero-Aragu\u00e1s","year":"2021","journal-title":"Semin Arthritis Rheum."},{"key":"B32","first-page":"132","article-title":"18F-FDG PET\/CT for assessing of disease activity of idiopathic inflammatory myopathies. A systematic review and meta-analysis. Hell J Nucl Med","volume":"24","author":"Kim","year":"2021"},{"key":"B33","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1007\/s00259-014-2961-x","article-title":"FDG PET\/CT: EANM procedure guidelines for tumour imaging: version 2","volume":"42","author":"Boellaard","year":"2015","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"B34","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.1007\/s00259-018-3973-8","article-title":"FDG-PET\/CT(A) imaging in large vessel vasculitis polymyalgia rheumatica: joint procedural recommendation of the EANM, SNMMI, the PET Interest Group (PIG), endorsed by the ASNC","volume":"45","year":"2018","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"B35","doi-asserted-by":"publisher","first-page":"e12954","DOI":"10.1111\/bpa.12954","article-title":"MRI and muscle imaging for idiopathic inflammatory myopathies","volume":"31","author":"Malartre","year":"2021","journal-title":"Brain Pathol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1056\/NEJM199202063260602","article-title":"Risk of cancer in patients with dermatomyositis or polymyositis. A population-based study","volume":"326","author":"Sigurgeirsson","year":"1992","journal-title":"N Engl J Med."},{"key":"B37","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/s11926-018-0731-7","article-title":"Management of interstitial lung disease in patients with myositis specific autoantibodies","volume":"20","author":"Mecoli","year":"2018","journal-title":"Curr Rheumatol Rep."},{"key":"B38","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1055\/s-0034-1371528","article-title":"Pulmonary manifestations of polymyositis\/dermatomyositis","volume":"35","author":"Hallowell","year":"2014","journal-title":"Semin Respir Crit Care Med."}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2022.883727\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,15]],"date-time":"2022-04-15T05:40:35Z","timestamp":1650001235000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2022.883727\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,15]]},"references-count":38,"alternative-id":["10.3389\/fmed.2022.883727"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2022.883727","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,15]]},"article-number":"883727"}}